DONNA HALL: Open Payments
NPI 1710984182 · WHITE HOUSE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,885 in 106 payments from 21 companies in 2025. Trend: 2023 $922 · 2024 $1,734 · 2025 $1,885
Food & beverage: $1,885
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $313 |
| Novo Nordisk Inc | 16 | $304 |
| PFIZER INC. | 14 | $219 |
| ABBVIE INC. | 16 | $177 |
| Lilly USA, LLC | 15 | $163 |
| Astellas Pharma US Inc | 6 | $124 |
| Otsuka America Pharmaceutical, Inc. | 5 | $86 |
| Phathom Pharmaceuticals, Inc. | 5 | $85 |
| Corcept Therapeutics | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $58 |
Products named: Ozempic, NURTEC ODT, BREZTRI, UBRELVY, Veozah, FARXIGA, REXULTI, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
